A muticenter study of Adalimumab in patients with Behcet's Syndrome

Trial Profile

A muticenter study of Adalimumab in patients with Behcet's Syndrome

Completed
Phase of Trial: Phase II

Latest Information Update: 17 Jun 2017

At a glance

  • Drugs Adalimumab (Primary)
  • Indications Behcet's syndrome
  • Focus Therapeutic Use
  • Most Recent Events

    • 17 Jun 2017 Short and long-term follow-up results (n=74) presented at the 18th Annual Congress of the European League Against Rheumatism
    • 22 Jul 2016 New trial record
    • 11 Jun 2016 Results presented at the 17th Annual Congress of the European League Against Rheumatism
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top